Contrast-induced nephropathy and mortality: possible crucial role of asymmetric dimethylarginine.
Andreotti
Felicita
F
Department of Cardiovascular Medicine, Catholic University, Rome, Italy. felicita.andreotti@iol.it
Santucci
Eleonora
E
Coluzzi
Giulio
G
D000111:Acetylcysteine / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D000975:Antioxidants / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D003287:Contrast Media / Q000009:adverse effects*; D017023:Coronary Angiography / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000401:mortality / Q000517:prevention & control; D009569:Nitric Oxide / Q000378:metabolism
D000975:Antioxidants; D015415:Biomarkers; D003287:Contrast Media; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D001120:Arginine; D000111:Acetylcysteine